PT  - JOURNAL ARTICLE
AU  - Abir, Tanvir
AU  - Kalimullah, Nazmul Ahsan
AU  - Osuagwu, Uchechukwu L
AU  - Nur –A Yazdani, Dewan Muhammad
AU  - Husain, Taha
AU  - Goson, Piwuna Christopher
AU  - Basak, Palash
AU  - Rahman, Md Adnan
AU  - Mamun, Abdullah Al
AU  - Permarupan, P. Yukthamarani
AU  - Khan, Md Yusuf Hossein
AU  - Agho, Kingsley
TI  - Prevalence and Factors associated with Mental health impact of COVID-19 Pandemic in Bangladesh: A survey based cross sectional study
AID  - 10.1101/2021.01.05.21249216
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.05.21249216
4099  - http://medrxiv.org/content/early/2021/01/09/2021.01.05.21249216.short
4100  - http://medrxiv.org/content/early/2021/01/09/2021.01.05.21249216.full
AB  - Background Feelings of isolation, insecurity, and instability triggered by COVID-19 could have a long-term impact on the mental health status of individuals. This study examined the prevalence and factors associated with the mental health symptoms of anxiety, depression, and stress during the COVID-19 pandemic in Bangladesh.Methods From 1st – 30th April 2020, we used a validated self-administered questionnaire to conduct a cross-sectional study on 10,609 participants through an online survey platform. We assessed mental health status using the Depression, Anxiety, and Stress Scale (DASS-21). The total depression, anxiety, and stress subscale scores were divided into normal, mild, moderate, severe, and multinomial logistic regression was used to examine associated factors.Results The prevalence of depressive symptoms was 15%, 34%, and 15% for mild, moderate, and severe depressive symptoms, respectively. The prevalence of anxiety symptoms was 59% for severe anxiety symptoms, 14% for moderate anxiety symptoms, and 14% for mild anxiety symptoms while, the prevalence for stress levels were 16% for severe stress level, 22% for moderate stress level and 13% for mild stress level. Multivariate analyses revealed that the most consistent factors associated with mild, moderate, and severe of the three mental health subscales (depression, anxiety, and stress) were respondents who lived in Dhaka and Rangpur division, females, those who self-quarantine in the previous 7 days before the survey and those respondents who experienced chills, breathing difficulty, dizziness, and sore throat.Conclusion Our results showed that about 64%, 87%, and 61% experienced depressive symptoms, anxiety symptoms, and levels of stress, respectively. In Bangladesh, there is a need for better mental health support for females especially those that lived in Dhaka and Rangpur division and experienced chills, breathing difficulty, dizziness, and sore throat during COVID-19 and other future pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: This research did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical permission for this study was obtained from the Institutional Review Board of Dr Wazed Research and Training Institute, Begum Rokeya University, Rangpur (#BRUR/DWRTI/a.n.004) and the study adhered to the tenets of the Declaration of Helsinki as revised in Fortaleza. All the participants were informed about the specific objective of this study before proceeding to the questionnaire. Consent was obtained from all participants prior to completing the questionnaire through an online preamble. Participants were able to complete the survey only once and could terminate the survey at any time they desired. Anonymity and confidentiality of the data were ensured.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is necessary that we stored the data in any repository. However, our data are included in the manuscript and raw data can be released on reasonable requests.